Literature DB >> 26656786

Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Laura Pattacini1, Jared M Baeten, Katherine K Thomas, Tayler R Fluharty, Pamela M Murnane, Deborah Donnell, Elizabeth Bukusi, Allan Ronald, Nelly Mugo, Jairam R Lingappa, Connie Celum, M Juliana McElrath, Jennifer M Lund.   

Abstract

OBJECTIVE: Two distinct hypotheses have been proposed for T-cell involvement in protection from HIV-1 acquisition. First, HIV-1-specific memory T-cell responses generated on HIV-1 exposure could mount an efficient response to HIV-1 and inhibit the establishment of an infection. Second, a lower level of immune activation could reduce the numbers of activated, HIV-1-susceptible CD4 T cells, thereby diminishing the likelihood of infection.
METHODS: To test these hypotheses, we conducted a prospective study among high-risk heterosexual men and women, and tested peripheral blood samples from individuals who subsequently acquired HIV-1 during follow-up (cases) and from a subset of those who remained HIV-1 uninfected (controls).
RESULTS: We found no difference in HIV-1-specific immune responses between cases and controls, but Treg frequency was higher in controls as compared with cases and was negatively associated with frequency of effector memory CD4 T cells.
CONCLUSIONS: Our findings support the hypothesis that low immune activation assists in protection from HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26656786      PMCID: PMC4866890          DOI: 10.1097/QAI.0000000000000919

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  54 in total

1.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers.

Authors:  J Lajoie; J Juno; A Burgener; S Rahman; K Mogk; C Wachihi; J Mwanjewe; F A Plummer; J Kimani; T B Ball; K R Fowke
Journal:  Mucosal Immunol       Date:  2012-02-08       Impact factor: 7.313

3.  Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.

Authors:  Fusheng Li; Uma Malhotra; Peter B Gilbert; Natalie R Hawkins; Ann C Duerr; Juliana M McElrath; Lawrence Corey; Steven G Self
Journal:  Vaccine       Date:  2006-06-27       Impact factor: 3.641

4.  Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission.

Authors:  T J Wasik; J Bratosiewicz; A Wierzbicki; V E Whiteman; R R Rutstein; S E Starr; S D Douglas; D Kaufman; A V Sison; M Polansky; H W Lischner; D Kozbor
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

5.  Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.

Authors:  Elijah M Songok; Ma Luo; Ben Liang; Paul Mclaren; Nadine Kaefer; Winnie Apidi; Genevieve Boucher; Joshua Kimani; Charles Wachihi; Rafick Sekaly; Keith Fowke; Blake T Ball; Francis A Plummer
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

Authors:  K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

Authors:  Scott M Hammer; Magdalena E Sobieszczyk; Holly Janes; Shelly T Karuna; Mark J Mulligan; Doug Grove; Beryl A Koblin; Susan P Buchbinder; Michael C Keefer; Georgia D Tomaras; Nicole Frahm; John Hural; Chuka Anude; Barney S Graham; Mary E Enama; Elizabeth Adams; Edwin DeJesus; Richard M Novak; Ian Frank; Carter Bentley; Shelly Ramirez; Rong Fu; Richard A Koup; John R Mascola; Gary J Nabel; David C Montefiori; James Kublin; M Juliana McElrath; Lawrence Corey; Peter B Gilbert
Journal:  N Engl J Med       Date:  2013-10-07       Impact factor: 91.245

9.  Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.

Authors:  N F Bernard; C M Yannakis; J S Lee; C M Tsoukas
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

10.  Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.

Authors:  Evélyne Bégaud; Loïc Chartier; Valéry Marechal; Julienne Ipero; Josianne Léal; Pierre Versmisse; Guillaume Breton; Arnaud Fontanet; Corinne Capoulade-Metay; Hervé Fleury; Françoise Barré-Sinoussi; Daniel Scott-Algara; Gianfranco Pancino
Journal:  Retrovirology       Date:  2006-06-22       Impact factor: 4.602

View more
  7 in total

1.  HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern.

Authors:  Brian Custer; Claire Quiner; Richard Haaland; Amy Martin; Mars Stone; Rita Reik; Whitney R Steele; Debra Kessler; Phillip C Williamson; Steven A Anderson; Alan E Williams; Henry F Raymond; Willi McFarland; William T Robinson; Sara Glick; Kwa Sey; C David Melton; Simone A Glynn; Susan L Stramer; Michael P Busch
Journal:  Blood       Date:  2020-09-10       Impact factor: 22.113

2.  Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women.

Authors:  Laura E Richert-Spuhler; Laura Pattacini; Margot Plews; Elizabeth Irungu; Timothy R Muwonge; Elly Katabira; Nelly Mugo; Adrienne F A Meyers; Connie Celum; Jared M Baeten; Jairam R Lingappa; Jennifer M Lund
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

3.  The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.

Authors:  Cassandra D Josephson; Simone Glynn; Sunitha Mathew; Rebecca Birch; Sonia Bakkour; Lisa Baumann Kreuziger; Michael P Busch; Kathleen Chapman; Carla Dinardo; Jeanne Hendrickson; Eldad A Hod; Shannon Kelly; Naomi Luban; Alan Mast; Philip Norris; Brian Custer; Ester Sabino; Bruce Sachais; Bryan R Spencer; Mars Stone; Steve Kleinman
Journal:  Transfusion       Date:  2022-04-19       Impact factor: 3.337

4.  Extensive Homeostatic T Cell Phenotypic Variation within the Collaborative Cross.

Authors:  Jessica B Graham; Jessica L Swarts; Michael Mooney; Gabrielle Choonoo; Sophia Jeng; Darla R Miller; Martin T Ferris; Shannon McWeeney; Jennifer M Lund
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

5.  Human Immunodeficiency Virus Proteins Mimic Human T Cell Receptors Inducing Cross-Reactive Antibodies.

Authors:  Robert Root-Bernstein
Journal:  Int J Mol Sci       Date:  2017-10-03       Impact factor: 5.923

6.  Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.

Authors:  Jessica B Graham; Jessica L Swarts; Vineet D Menachery; Lisa E Gralinski; Alexandra Schäfer; Kenneth S Plante; Clayton R Morrison; Kathleen M Voss; Richard Green; Gabrielle Choonoo; Sophia Jeng; Darla R Miller; Michael A Mooney; Shannon K McWeeney; Martin T Ferris; Fernando Pardo-Manuel de Villena; Michael Gale; Mark T Heise; Ralph S Baric; Jennifer M Lund
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226

Review 7.  Impact of Endemic Infections on HIV Susceptibility in Sub-Saharan Africa.

Authors:  Sergey Yegorov; Vineet Joag; Ronald M Galiwango; Sara V Good; Brenda Okech; Rupert Kaul
Journal:  Trop Dis Travel Med Vaccines       Date:  2019-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.